» Articles » PMID: 2890433

Immunodetection and Modulation of Cellular Growth with Antibodies Against Native Transforming Growth Factor-beta 1

Overview
Journal Cancer Res
Specialty Oncology
Date 1987 Dec 15
PMID 2890433
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

In an attempt to identify and quantitate latent and active forms of transforming growth factor beta (TGF beta) without the use of cell cultures and to test for autocrine stimulation by TGF beta, rabbit antibodies were raised against native human and porcine platelet-derived TGF beta. A radioimmunoassay for TGF beta was developed using radioiodinated TGF beta, anti-TGF beta antibodies, and protein A. Inhibition in the radioimmunoassay was achieved with nanogram quantities of TGF beta, comparable to the sensitivity of radioreceptor assays. Analyses of the TGF beta levels of conditioned medium from cultured cells indicated that the latent form(s) of TGF beta is not detectable in the radioimmunoassay established using antibodies raised against native TGF beta. Immunoprecipitation analysis of radiolabeled conditioned medium revealed a specific Mr 25,000 band only after acidification. A Mr 62,000 protein was observed with and without prior acidification of the medium but could not be competed with unlabeled TGF beta in the immunoprecipitation indicating antigenic unrelatedness. The anti-TGF beta IgG inhibited the binding of [125I]TGF beta to the cell surface receptors in a radioreceptor assay. TGF beta inhibition of A549 cell growth was reversed by the antibodies, which also neutralized the growth inhibitory effects of TGF beta on AKR-2B cells in a monolayer [3H]thymidine incorporation assay as demonstrated by prevention of TGF beta inhibition of insulin and epidermal growth factor-stimulated DNA synthesis. The antibodies also effectively inhibited spontaneous soft agar growth of AKR-MCA fibroblasts, providing evidence for autocrine secretion of TGF beta as a mechanism of their anchorage-independent growth.

Citing Articles

The Novel Small Molecule BTB Inhibits Pro-Fibrotic Fibroblast Behavior though Inhibition of RhoA Activity.

Rackow A, Nagel D, Zapas G, Clough R, Sime P, Kottmann R Int J Mol Sci. 2022; 23(19).

PMID: 36233248 PMC: 9569993. DOI: 10.3390/ijms231911946.


Erbin and the NF2 tumor suppressor Merlin cooperatively regulate cell-type-specific activation of PAK2 by TGF-beta.

Wilkes M, Repellin C, Hong M, Bracamonte M, Penheiter S, Borg J Dev Cell. 2009; 16(3):433-44.

PMID: 19289088 PMC: 2792748. DOI: 10.1016/j.devcel.2009.01.009.


Dynamics of Vascular Remodeling: An Overview and Bibliography.

Bortman , Losordo J Thromb Thrombolysis. 1996; 3(1):71-86.

PMID: 10608041 DOI: 10.1007/BF00226415.


Cytokines in tumour growth, migration and metastasis.

Negus R, Balkwill F World J Urol. 1996; 14(3):157-65.

PMID: 8806194 DOI: 10.1007/BF00186895.


Anti-(transforming growth factor beta) antibodies with predefined specificity inhibit metastasis of highly tumorigenic human xenotransplants in nu/nu mice.

Hoefer M, Anderer F Cancer Immunol Immunother. 1995; 41(5):302-8.

PMID: 8536276 PMC: 11037827. DOI: 10.1007/BF01517218.